Related Experiment Video
Updated: Jul 6, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP
L L Santos1, A Dacumos, J Yamana
1Monash University, Department of Medicine, Monash Medical Centre, Clayton, Melbourne, Victoria, Australia. lanie.santos@med.monash.edu.au
Abstract:
Macrophage migration inhibitory factor (MIF) is a pleiotropic pro-inflammatory cytokine with many cellular targets in rheumatoid arthritis (RA). MIF has been reported to activate cells via mitogen-activated protein kinase and serine/threonine kinase (AKT or protein kinase B)-dependent signal transduction pathways. Its contribution to T cell activation and signalling in RA is not known. Using MIF -/- mice and a T cell-mediated model of RA, antigen-induced arthritis, we investigated the role of MIF in T cell activation and signalling. Arthritis severity was significantly reduced in MIF -/- mice compared with wildtype mice. This reduction was associated with decreased T cell activation parameters including footpad delayed type hypersensitivity, antigen-induced splenocyte proliferation and cytokine production. Splenocyte proliferation required extracellular signal-regulated kinase (ERK)1/2 phosphorylation, and decreased T cell activation in MIF -/- mice was associated with decreased phosphorylation of ERK1/2 but not AKT. Collectively, these data suggest that MIF promotes antigen-specific immune responses via regulation of ERK phosphorylation in T cells.
Insights
Macrophage migration inhibitory factor (MIF) plays a key role in rheumatoid arthritis (RA) by promoting T cell activation. Reducing MIF levels in mice significantly decreased RA severity and T cell responses, highlighting MIF
Area of Science:
- Immunology
- Rheumatology
- Molecular Biology
Background:
- Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine implicated in rheumatoid arthritis (RA).
- MIF signaling pathways involve mitogen-activated protein kinase and AKT.
- The specific role of MIF in T cell activation and signaling in RA remains unclear.
Purpose of the Study:
- To investigate the role of MIF in T cell activation and signaling within a T cell-mediated model of RA.
Main Methods:
- Utilized MIF knockout (MIF -/-) mice and an antigen-induced arthritis model.
- Assessed arthritis severity, delayed type hypersensitivity, splenocyte proliferation, and cytokine production.
- Analyzed extracellular signal-regulated kinase (ERK)1/2 and AKT phosphorylation in T cells.
Main Results:
- MIF -/- mice exhibited significantly reduced arthritis severity compared to wildtype mice.
- Decreased T cell activation, including reduced splenocyte proliferation and cytokine production, was observed in MIF -/- mice.
- Reduced T cell activation in MIF -/- mice correlated with decreased ERK1/2 phosphorylation, but not AKT phosphorylation.
Conclusions:
- MIF promotes antigen-specific immune responses in RA through the regulation of ERK phosphorylation in T cells.
- These findings identify MIF as a potential therapeutic target for RA by modulating T cell signaling.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway
